11 – 20 of 29
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2007
-
Mark
Oxidized LDL antibodies in treatment and risk assessment of atherosclerosis and associated cardiovascular disease.
(
- Contribution to journal › Scientific review
-
Mark
Autoantibody against the amino acid sequence 661-680 in apo B-100 is associated with decreased carotid stenosis and cardiovascular events.
2007) In Atherosclerosis(
- Contribution to journal › Article
-
Mark
Autoimmune responses against the apo B-100 LDL receptor-binding site protect against arterial accumulation of lipids in LDL receptor deficient mice.
(
- Contribution to journal › Article
-
Mark
Immunomodulation of atherosclerosis
2007) p.371-382(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Association between IgM against an aldehyde-modified peptide in apolipoprotein B-100 and progression of carotid disease
(
- Contribution to journal › Article
-
Mark
Recombinant antibodies to an oxidized low-density lipoprotein epitope induce rapid regression of atherosclerosis in apobec-1(-/-)/low-density lipoprotein receptor(-/-) mice.
(
- Contribution to journal › Article
- 2006
-
Mark
Oxidized lipoprotein autoimmunity: an emerging drug target in cardiovascular disease
(
- Contribution to journal › Scientific review
-
Mark
Identification of autoantibodies in human plasma recognizing an apoB-100 LDL receptor binding site peptide
(
- Contribution to journal › Article
- 2005
-
Mark
Immunomodulation of Atherosclerosis. Implications for Vaccine Development.
(
- Contribution to journal › Scientific review
-
Mark
Atheroprotective immunization with MDA-modified apo B-100 peptide sequences is associated with activation of Th2 specific antibody expression.
(
- Contribution to journal › Article